Analysis of Radiographic and Kinematic Features in FAI Patients
NCT ID: NCT05867069
Last Updated: 2023-05-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
93 participants
OBSERVATIONAL
2021-09-01
2022-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Is structural knee abnormalities associated with knee pain symptoms in FAI patients?
* Does FAI patients with knee pain demonstrate unique kinematic characteristics? Participants will receive routine preoperative radiographic examinations, which include ipsilateral knee MRI for the purpose of femoral version measurement. Participants will also receive markerless motion capture analysis.
Researchers will compare preoperative radiographic and kinematic features based on knee pain status, which is routinely collected as part of clinical investigation procedures.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Mechanism for the Effects of Joint Biomechanical Properties on Medial Cartilage of Tibiofemoral Joint Degeneration
NCT04968665
Hip Muscle Strength in FAI Versus Normal Controls
NCT02697097
Application of FMRI in Diagnosis of Anterior Cruciate Ligament Injury
NCT04958915
Femoral External Rotation Measured on CT and MRI
NCT05327413
Muscle Strength Loss and Its Effect on Knee Cap Motion in Volunteers With Anterior Knee Pain
NCT01862731
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ipsilateral knee pain group
Those FAI patients presenting with preoperative ipsilateral knee pain.
No interventions assigned to this group
No ipsilateral knee pain group
Those FAI patients presenting without preoperative ipsilateral knee pain.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* (2) failed conservative treatment for at least 6 months and indicated for surgical treatment;
* (3) received routine preoperative hip and ipsilateral knee MRI.
Exclusion Criteria
* (2) avascular necrosis;
* (3) Legg-Calve-Perthes disease;
* (4) Ehlers-Danlos syndrome;
* (5) pigmented villonodular synovitis (PVNS);
* (6) osteoid osteoma (OO);
* (7) synovial chondromatosis;
* (8) severe hip osteoarthritis (OA) with Tönnis grade \> 1;
* (9) developmental dysplasia of hip (DDH)
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Peking University Third Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yan Xu, M.D.
Role: PRINCIPAL_INVESTIGATOR
Peking University Third Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Peking University Third Hospital
Beijing, , China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
S2021436
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.